Stratos Wealth Partners, Ltd. Moderna, Inc. Transaction History

Stratos Wealth Partners, Ltd.

$6.14 Billion
Q2 2024

A detailed history of Stratos Wealth Partners, Ltd. transactions in Moderna, Inc. stock. As of the latest transaction made, Stratos Wealth Partners, Ltd. holds 3,649 shares of MRNA stock, worth $239,921. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,649

Previous 5,692 35.89%

Holding current value

$239,921

Previous $606,000 28.55%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	SELL	$101.21 - $166.61 $206,772 - $340,384	-2,043 Reduced 35.89%	3,649 $433,000
Q1 2024 Apr 16, 2024	BUY	$85.37 - $115.44 $46,697 - $63,145	547 Added 10.63%	5,692 $606,000
Q4 2023 Jan 24, 2024	SELL	$69.51 - $104.43 $78,268 - $117,588	-1,126 Reduced 17.96%	5,145 $511,000
Q3 2023 Oct 24, 2023	SELL	$96.41 - $126.61 $162,836 - $213,844	-1,689 Reduced 21.22%	6,271 $647,000
Q2 2023 Jul 18, 2023	BUY	$118.5 - $160.53 $214,603 - $290,719	1,811 Added 29.45%	7,960 $967,000
Q1 2023 Apr 27, 2023	SELL	$135.66 - $197.02 $127,791 - $185,592	-942 Reduced 13.28%	6,149 $944,000
Q4 2022 Jan 19, 2023	BUY	$118.38 - $210.04 $7,221 - $12,812	61 Added 0.87%	7,091 $0
Q3 2022 Oct 24, 2022	SELL	$118.07 - $194.18 $262,823 - $432,244	-2,226 Reduced 24.05%	7,030 $831,000
Q2 2022 Jul 22, 2022	SELL	$117.13 - $176.59 $60,439 - $91,120	-516 Reduced 5.28%	9,256 $1.32 Million
Q1 2022 Apr 26, 2022	BUY	$126.46 - $235.05 $133,541 - $248,212	1,056 Added 12.12%	9,772 $1.68 Million
Q4 2021 Jan 14, 2022	SELL	$225.82 - $368.51 $1.48 Million - $2.42 Million	-6,557 Reduced 42.93%	8,716 $2.21 Million
Q3 2021 Oct 19, 2021	SELL	$221.9 - $484.47 $496,612 - $1.08 Million	-2,238 Reduced 12.78%	15,273 $5.88 Million
Q2 2021 Jul 19, 2021	BUY	$129.91 - $234.98 $32,867 - $59,449	253 Added 1.47%	17,511 $4.12 Million
Q1 2021 Apr 27, 2021	BUY	$109.18 - $185.98 $4,476 - $7,625	41 Added 0.24%	17,258 $2.26 Million
Q4 2020 Jan 29, 2021	BUY	$65.74 - $169.86 $399,567 - $1.03 Million	6,078 Added 54.57%	17,217 $1.8 Million
Q3 2020 Oct 29, 2020	BUY	$54.34 - $94.85 $175,463 - $306,270	3,229 Added 40.82%	11,139 $788,000
Q2 2020 Jul 28, 2020	BUY	$29.67 - $80.0 $234,689 - $632,800	7,910 New	7,910 $508,000

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.

Account

Stratos Wealth Partners, Ltd. Moderna, Inc. Transaction History